The analysis of 10x diluted CSF samples led to negative SAA results in one AD/ALB and one CJD/LBP sample (Fig. 5B), corresponding to 85.7% (95% CI 57.2–98.2%) assay sensitivity. This evidence concerns the gene ALB and Alzheimer disease.